Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kohjin Bio CoTSE:177A +1.57%19 PS Ratio is 0.94 as of Jul. 28, 2026, which is 37% below its 10-year median of 1.50. GuruFocus rates TSE:177A with a GF Score™ of 19/100. The stock has 3 warning signs investors should review. Among 929 Biotechnology companies, Kohjin Bio Co ranks better than 93.22% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Kohjin Bio Co's share price is 円904.00.
Kohjin Bio Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円966.16. Hence, Kohjin Bio Co's PS Ratio for today is 0.94.
Good Sign:
Kohjin Bio Co Ltd stock PS Ratio (=0.92) is close to 3-year low of 0.89.
The historical rank and industry rank for Kohjin Bio Co's PS Ratio or its related term are showing as below:
TSE:177A'
s PS Ratio Range Over the Past 10 Years
Min: 0.89 Med: 1.5 Max: 2.14
Current: 0.93
During the past 5 years, Kohjin Bio Co's highest PS Ratio was 2.14. The lowest was 0.89. And the median was 1.50.
TSE:177A's PS Ratio is ranked better than 93.22% of 929
companies
in the Biotechnology industry
Industry Median: 9.06
vs TSE:177A: 0.93
Kohjin Bio Co Ltd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Kohjin Bio Co was -6.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -5.30% per year.
During the past 5 years, Kohjin Bio Co's highest 3-Year average Revenue per Share Growth Rate was 9.50% per year. The lowest was -5.30% per year. And the median was 2.10% per year.
Back to Basics: PS Ratio
Kohjin Bio Co (TSE:177A) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Kohjin Bio Co PS Ratio Related Terms
Kohjin Bio Co PS Ratio Historical Data
* Premium members only.
The historical data trend for Kohjin Bio Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Kohjin Bio Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kohjin Bio Co PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Kohjin Bio Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Kohjin Bio Co's Share Price of today is 円904.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kohjin Bio Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円966.16.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Kohjin Bio Co (TSE:177A) has a PS Ratio of 0.94 as of Jul. 28, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Kohjin Bio Co and its competitors. This is 37% below median its historical median of 1.50. Over the past decade, Kohjin Bio Co's PS Ratio has ranged from 0.89 to 2.14. According to the industry distribution chart, Kohjin Bio Co ranks #63 out of 929 companies in the Biotechnology industry, placing it in the top 6.8%.
Is Kohjin Bio Co's PS Ratio too high?
Kohjin Bio Co's current PS Ratio of 0.94 is 37% below median its 10-year median of 1.50. Over the past 10 years, this metric has ranged from a low of 0.89 to a high of 2.14. The Biotechnology industry median PS Ratio is 9.06. Kohjin Bio Co's value of 0.94 is 89.6% below this industry median. Based on the distribution chart, Kohjin Bio Co ranks #63 out of 929 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Kohjin Bio Co has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kohjin Bio Co ranks #63 out of 929 companies for PS Ratio. This places Kohjin Bio Co in the top 7% of its industry — outperforming the majority of peers. The industry median PS Ratio is 9.06. Kohjin Bio Co's value of 0.94 is 89.6% below this benchmark. Historically, Kohjin Bio Co's own PS Ratio has ranged from 0.89 to 2.14 over the past decade. While the company's 10-year median is 1.50 vs. the industry median of 9.06, Kohjin Bio Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.06, based on 929 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kohjin Bio Co's current PS Ratio of 0.94 is 89.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Kohjin Bio Co and its competitors. For the Biotechnology industry, the median PS Ratio is 9.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kohjin Bio Co's current PS Ratio is 0.94, which is 37% below median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current PS Ratio of 0.94. The current PS Ratio is 0.94, which is 37% below median its 10-year median of 1.50 and 89.6% below the Biotechnology industry median of 9.06. Kohjin Bio Co's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current PS Ratio is 0.94 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
19GF Score
Get the complete analysis for TSE:177A
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:177A has been successfully added to your 
